Micafungina, una nueva candina para el tratamiento de las micosis invasoras

Palacio, Amalia del; Pontón, José; Quindós, Guillermo.
Rev. iberoam. micol ; 26(1): 1-1, mar. 2009.
Artículo en Español | IBECS (España) | ID: ibc-136097

Documentos relacionados

  1. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
  2. Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia.
  3. Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.
  4. Rezafungin and invasive candida infections: a new game changing antifungal?
  5. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.
  6. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
  7. New developments and directions in the clinical application of the echinocandins.
  8. Update on the treatment of chronic pulmonary aspergillosis.
  9. Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta-analysis.
  10. Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.